Related Experiment Videos
Bullous pemphigoid after treatment with furosemide
C A Koch1, E L Mazzaferri, J A Larry
1Ohio State University, Department of Internal Medicine, Columbus, USA.
Cutis
|November 1, 1996
Summary
Bullous pemphigoid (BP) is a blistering skin disease. This case study highlights furosemide as a potential drug trigger for BP, emphasizing its consideration in patients with new blistering lesions.
Area of Science:
- Dermatology
- Immunofluorescence
- Drug-induced skin reactions
Background:
- Bullous pemphigoid (BP) is a subepidermal blistering skin disease.
- Diagnosis relies heavily on direct immunofluorescence.
- Certain medications are known risk factors for BP induction.
Observation:
- The association between BP and furosemide is infrequently reported and debated.
- This report details a patient who developed BP following intravenous furosemide administration.
- A review of existing literature on furosemide-induced BP is included.
Findings:
- Furosemide is presented as a potential, albeit rare, cause of drug-induced bullous pemphigoid.
- The study supports considering furosemide as an inciting agent in specific BP cases.
- Direct immunofluorescence confirmed the diagnosis in the presented patient.
Implications:
- Clinicians should consider drug-induced BP in patients presenting with bullous lesions after medication use.
- Furosemide should be recognized as a possible trigger for bullous pemphigoid.
- Further research may clarify the specific mechanisms and frequency of furosemide-induced BP.